287 related articles for article (PubMed ID: 30738982)
1. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.
Subrizi A; Del Amo EM; Korzhikov-Vlakh V; Tennikova T; Ruponen M; Urtti A
Drug Discov Today; 2019 Aug; 24(8):1446-1457. PubMed ID: 30738982
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
[TBL] [Abstract][Full Text] [Related]
4. Ocular delivery systems for topical application of anti-infective agents.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
[TBL] [Abstract][Full Text] [Related]
5. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
6. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
Üstündağ Okur N; Çağlar EŞ; Siafaka PI
J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
[TBL] [Abstract][Full Text] [Related]
7. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
Singh M; Bharadwaj S; Lee KE; Kang SG
J Control Release; 2020 Dec; 328():895-916. PubMed ID: 33069743
[TBL] [Abstract][Full Text] [Related]
9. Controlled and continuous release ocular drug delivery systems: pros and cons.
Abdelkader H; Alany RG
Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
[TBL] [Abstract][Full Text] [Related]
10. Advances and limitations of drug delivery systems formulated as eye drops.
Jumelle C; Gholizadeh S; Annabi N; Dana R
J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
[TBL] [Abstract][Full Text] [Related]
11. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
12. Nanomaterials for ocular drug delivery.
Liu S; Jones L; Gu FX
Macromol Biosci; 2012 May; 12(5):608-20. PubMed ID: 22508445
[TBL] [Abstract][Full Text] [Related]
13. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
Shen J; Lu GW; Hughes P
Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in ocular drug delivery.
Chen H
J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
[TBL] [Abstract][Full Text] [Related]
15. Ocular drug bioavailability from topically applied liposomes.
Lee VH; Urrea PT; Smith RE; Schanzlin DJ
Surv Ophthalmol; 1985; 29(5):335-48. PubMed ID: 3992472
[TBL] [Abstract][Full Text] [Related]
16. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
17. Polymer-based carriers for ophthalmic drug delivery.
Imperiale JC; Acosta GB; Sosnik A
J Control Release; 2018 Sep; 285():106-141. PubMed ID: 29964135
[TBL] [Abstract][Full Text] [Related]
18. Recent Advancemnts in Biodegradable Ocular Implants.
Mittal S; Miranda O
Curr Drug Deliv; 2018 Feb; 15(2):144-154. PubMed ID: 28482784
[TBL] [Abstract][Full Text] [Related]
19. Improvement in Ocular Bioavailability and Prolonged Delivery of Tobramycin Sulfate Following Topical Ophthalmic Administration of Drug-Loaded Mucoadhesive Microparticles Incorporated in Thermosensitive In Situ Gel.
Khan S; Warade S; Singhavi DJ
J Ocul Pharmacol Ther; 2018 Apr; 34(3):287-297. PubMed ID: 29211593
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic drug dosage forms: characterisation and research methods.
Baranowski P; Karolewicz B; Gajda M; Pluta J
ScientificWorldJournal; 2014; 2014():861904. PubMed ID: 24772038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]